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Abstract
Background: We aimed to assess in-hospital outcomes of percutaneous transluminal coro-
nary angioplasty (PTCA) in elderly subjects.
Methods: A total of 1000 consecutive patients, who had all been admitted for interventional
treatment of symptomatic coronary artery disease, were retrospectively analysed.
Results: Elderly patients (‡ 70 years of age) were more likely to be diabetic, hypertensive and
of female gender. They more frequently were diagnosed with chronic heart failure as well as
prior stroke. Significantly higher proportions of the elderly population presented with
cardiogenic shock and underwent PTCA as a result of acute coronary syndromes. Multivessel
coronary disease affected a large majority of senior patients. Although stenting dominated in
both age groups, balloon angioplasty was relatively more frequently applied in the elderly.
Coronary angioplasty in elderly patients was associated with fewer direct stenting procedures,
longer exposure to X-rays and a higher volume of the contrast medium. The efficacy of inter-
vention, assessed according to clinical and angiographic criteria, was high in both groups,
although revascularisation was significantly less complete while crude in-hospital mortality
higher in the elderly group. Advanced age remained an independent predictor of both increased
in-hospital mortality and longer exposure to X-rays after an adjustment for the baseline
characteristics in multivariable analyses.
Conclusions: Despite frequent comorbidities and more extensive coronary athersoclerosis,
a high rate of procedural success was achieved in the elderly population who underwent PTCA.
However, after an adjustment for the baseline characteristics advanced age was still associated
with a less favourable in-hospital outcome and a higher degree of procedural complexity.
(Cardiol J 2007; 14: 143154)
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Introduction
The dynamic progress made in medical tech-
nologies over the last couple of decades has pro-
vided modern, technologically advanced and in-
creasingly more effective therapeutic options, re-
sulting in extension of the human life span. The
continuous ageing of the population is becoming
a serious problem for healthcare systems in highly
developed countries since the burden of coronary
artery disease (CAD) increases with the ageing of
society.
The choice of optimal CAD treatment in the
elderly remains a difficult task within the context
of the evidence-based medicine so commonly incor-
porated into decision-making chains nowadays. The
elderly population is only poorly represented in ran-
domised trials on CAD management [15]. There-
fore the approach in this particular clinical setting
has not been firmly established.
In subjects presenting with ST-segment ele-
vation myocardial infarction (STEMI) the major lim-
itations of pharmacological reperfusion therapy (nu-
merous contraindications, poor tolerance, increased
risk of bleeding and low final effectiveness) often
make this method of treatment inappropriate for
this age group. It is estimated that only one third of
elderly STEMI patients are eligible to receive fi-
brynolytic therapy [6]. On the other hand, invasive
strategy in elderly people is also believed to be as-
sociated with a higher procedural risk, owing to
advanced disseminated atherosclerotic lesions, and
also with a higher rate of antiplatelet therapy-re-
lated complications [79].
The aim of our study was to assess in-hospital
outcomes of percutaneous transluminal coronary
angioplasty (PTCA) in patients ‡ 70 years of age
as compared with younger patients.
Methods
Study design and patients
A total of 1000 consecutive patients were ret-
rospectively enrolled into a single academic centre
registry. All the subjects were admitted to the De-
partment of Cardiology and Internal Diseases of the
University Hospital in Bydgoszcz between June 2002
and April 2003 for interventional treatment of symp-
tomatic CAD. The participants were divided accord-
ing to age into two subgroups of ‡ 70 years of age
(233 patients) and < 70 years of age (767 patients).
Percutaneous transluminal coronary angioplasty
was performed in three modes, the choice depend-
ing on the clinical status of the individual patient:
 elective, for stable angina (SA)  492 patients
(49.2%);
 urgent, for unstable angina (UA)/non-ST-seg-
ment elevation myocardial infarction (NSTEMI)
 164 patients (16.4%);
 emergency, for STEMI  344 patients (34.4%).
The inclusion criterion was the presence of
significant (> 50% of artery diameter) stenosis
in ‡ 1 coronary artery supplying viable myocar-
dial tissue. Patients with significant stenosis of
the left main trunk were excluded from the study.
All intervention was carried out in compliance
with standard guidelines using a Toshiba CAS-10A
angiography device. Each PTCA procedure was
preceded by an angiographic study. Bare metal
stents were implanted at the operators discre-
tion. In each case the patients written informed
consent for coronary angioplasty was required.
The study protocol was approved by the local eth-
ics committee.
The patients invasive treatment charts,
their angiographic recordings and their hospital
medical records were analysed. The demograph-
ic and clinical characteristics of the study popu-
lation are presented in Table 1, while the distri-
bution of selected angiographic and procedural
features in the groups compared are displayed
in Table 2.
Patient management depended on the mode of
qualification for the invasive procedure. Elective
procedures were preceded by oral administration
of aspirin (75150 mg once daily) to all patients and
additional administration of ticlopidine 250 mg twice
daily at least 72 hours prior to the intervention.
Patients qualified for urgent/emergency procedure
were pretreated with a 300 mg loading dose of clopi-
dogrel. Independently of the mode of management,
unless contraindicated, each patient was given un-
fractionated heparin intravenously (100 IU/kg) and
an intracoronary bolus of nitroglycerin (0.3 mg) di-
rectly prior to the procedure. Only iso-osmolar or
low-osmolar non-ionic contrast media were used.
After stent implantation each patient received
75 mg aspirin once daily indefinitely and ticlopidine
250 mg twice daily for 4 weeks. Other medications
were given when indicated by international recom-
mendations [1012].
Statistical analysis
Quantitative and qualitative data were respec-
tively expressed as arithmetical mean – standard
deviation and the sum and percentage of patients
within the analysed group presenting with a parti-
cular feature. Arithmetical means and percentage
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values were rounded off to one decimal place and
relative risk values and the results of multiple re-
gression to two and four decimal places respective-
ly. Examination of normal distribution of quantita-
tive variables was performed using the Kol-
mogorov-Smirnow test. Continuous variables
showing normal distribution were compared using
the t-test for the difference between two means of
independent variables. The Mann-Whitney test was
applied to compare variables which did not show
Gaussian distribution. Independent prognostic fac-
tors of the short-term outcome were determined
with the logistic regression model. Relations be-
tween the variables investigated and the likelihood
of in-hospital mortality were estimated with the use
of odds ratios (OR) and their 95% confidence inter-
vals (95% CI). A multiple-regression model was
used to evaluate the independent impact of multi-
ple variables on a continuous variable. Qualitative
data were analysed and compared using the c2 test
(applying Yeats correction when indicated) or us-
ing the Fisher exact test. A value of p < 0.05 was
considered statistically significant, 0.05 £ p < 0.1
was regarded as a trend towards statistical signifi-
cance, and p ‡ 0.1 was marked as NS. The abbrevi-
ation NM indicates failure in test performance as
a result of the violation of test assumptions. All com-
putations were carried out with Statistica, version 7.1
(StatSoft, Tulsa, USA).
Results
Patient and procedure characteristics
As indicated in Table 1, elderly patients were
more likely to be diabetic, hypertensive and of fe-
male gender. They more frequently had a history
of chronic heart failure and stroke as well as pre-
senting more often with cardiogenic shock on ad-
mission. A significantly higher proportion of them
underwent percutaneous revascularisation as a re-
sult of acute coronary syndromes. In contrast, uni-
variate analysis revealed more past and current
smokers, a greater prevalence of hypercholestero-
laemia and a family history of CAD in subjects aged
under 70 years.
Multivessel coronary disease affected a large
majority of elderly patients (81.1% vs. 63.8% in
younger subjects, p < 0.00001) (Table 2). The eld-
erly and younger subjects did not differ in terms of
the localisation of the culprit lesion or baseline TIMI
flow in the culprit vessel. The final TIMI flow
achieved was also comparable in the two groups.
Although coronary stenting dominated in both age
groups, balloon angioplasty was relatively more fre-
quently applied in elderly patients. Furthermore, in
univariate analysis we observed fewer direct stent-
ing procedures in the latter group. Recanalisation
of chronically occluded vessels and simultaneous
multivessel interventions were performed in
Table 1. Demographic and clinical characteristics of the groups analysed.
Parameters Patients ‡ 70 years Patients < 70 years p
(n = 233)  (n = 767)
Gender [male/female] 138/95 563/204 < 0.00004
Age [years] 74.6 – 4.6 55.7 – 8.0 < 0.000001
Indications for PTCA:
stable angina  89 (38.2%)  403 (52.5%)
unstable angina/non-ST-elevation 52 (22.3%) 112 (14.6%) < 0.0004
myocardial infarction
ST-elevation myocardial infarction 92 (39.5%)   252 (32.9%)
Cardiogenic shock on admission 18 (7.7%) 23 (3.0%) < 0.002
Previous myocardial infarction 105 (45.1%) 349 (45.5%) NS
Chronic heart failure 56 (24.0%) 89 (11.6%) < 0.00001
Previous stroke 19 (8.1%) 36 (4.7%) < 0.05
Peripheral arterial disease 15 (6.4%) 51 (6.6%) NS
Hypertension 163 (69.9%) 443 (57.7%) < 0.001
Diabetes mellitus 56 (24.0%) 136 (17.7%) < 0.04
Smoking:
ever 99 (42.5%) 532 (69.4%)
never 134 (57.5%) 235 (30.6%)
Body mass index [kg/m2] 27.0 – 3.8 27.5 – 3.8 0.053
Hypercholesterolaemia 168 (72.1%) 640 (83.4%) < 0.0002
Family history of ischaemic heart disease 37 (15.9%) 241 (31.4%) < 0.00001
< 0.00001
146
Cardiology Journal 2007, Vol. 14, No. 2
www.cardiologyjournal.org
Table 2. Distribution of selected angiographic and procedural features in the groups compared.
Patients ‡ 70 years Patients < 70 years p
(n = 233)  (n = 767)
Coronary artery disease:
single-vessel 44 (18.9%) 278 (36.2%)
multivessel 189 (81.1%) 489 (63.8%)
Localisation of culprit lesion:
right coronary artery 79 (33.9%) 292 (38.1%)
left coronary artery 153 (65.7%) 467 (60.9%)
saphenous venous graft 1 (0.4%) 7 (0.9%)
left internal mammary artery 0 (0%) 1 (0.1%)
Baseline blood flow in the culprit vessel:
TIMI 0 or 1 86 (36.9%) 274 (35.7%)
TIMI 2 or 3 147 (63.1%) 493 (64.3%)
Final blood flow in the culprit vessel:
TIMI 0 or 1 16 (6.9%) 47 (6.1%)
TIMI 2 or 3 217 (93.1%) 720 (93.9%)
Usage of abciximab 51 (21.9%) 135 (17.6%) NS
Recanalisation 23 (9.9%) 85 (11.1%) NS
Multivessel PTCA 11 (4.7%) 18 (2.9%) NS
Applied PTCA method:
POBA 52 (23.4%) 126 (16.5%)
stenting  181 (76.6%)   641 (83.5%)
Direct stenting 46 (19.7%) 225 (29.3%) < 0.004
Maximal stent or balloon length [mm] 18.1 – 6.0 17.2 – 5.4 < 0.04
Maximal stent or balloon diameter [mm] 3.0 – 0.5 3.1 – 0.5 < 0.003
Maximal inflation pressure [atm] 13.1 – 3.3 13.6 – 3.4 0.069
Number of used balloons:
0 47 (20.2%) 199 (25.9%)
1 121 (51.9%) 378 (49.3%)
2 54 (23.2%) 162 (21.1%)
3 11 (4.7%) 28 (3.7%)
Number of implanted stents:
0 52 (22.3%) 126 (16.4%)
1 145 (62.2%) 547 (71.3%)
2 28 (12.0%) 81 (10.6%)
3 8 (3.5%) 13 (1.7%)
X-ray exposure time [min] 11.1 – 7.3 9.5 – 6.2 < 0.001
Duration of PTCA [min] 40.7 – 22.2 38.5 – 20.0 NS
Volume of dye used [ml] 160.2 – 87.2 149.2 – 75.1 0.060
Angiographic outcome of PTCA:
effective 213 (91.4%) 718 (93.6%)
ineffective 20 (8.4%) 49 (6.4%)
Revascularisation:
complete 28 (12.0%) 205 (26.7%)
incomplete 205 (88.0%) 524 (73.3%)
Qualification for further treatment:
conservative 180 (77.3%) 643 (83.8%)
PTCA 45 (19.3%) 110 (14.3%) 0.052
CABG 8 (3.4%) 14 (1.9%)
*Saphenous venous grafts and left internal mammary arteries were analysed as one group; POBA  plain old balloon angioplasty, PTCA  percutaneous
transluminal coronary angioplasty, CABG  coronary artery bypass grafting
< 0.00001
NS*
NS
< 0.04
NS
NS
NS
< 0.0001
NS
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similar proportions in the two groups. Culprit sten-
oses were markedly longer, while reference lumen
diameters were narrower in the elderly subjects.
In this population stents were deployed and balloons
inflated with lower maximal pressure than in young-
er individuals. However, the average number of
implanted stents and used balloons did not differ
between the groups. Coronary angioplasty in the
elderly population was associated with a remarka-
bly longer exposure to X-rays.  We also noted
a trend towards a higher volume of the administered
contrast medium in senior patients. The efficacy of
intervention was high in both groups (angiographic
effectiveness in 91.4% vs. 93.6% of cases, final
TIMI 2 or 3 flow in culprit vessel 93.1% vs. 93.9%),
although in the elderly group revascularisation was
significantly less complete and qualification for
staged percutaneous procedures was more fre-
quent.
In-hospital mortality and
duration of hospitalisation
We observed an unadjusted in-hospital mortal-
ity rate of 6.9% in senior patients compared with
2.1% in subjects aged below 70 years (p < 0.0003).
A subgroup analysis of the in-hospital mortality with
respect to the indications for PTCA revealed a sta-
tistically higher rate of mortality among elderly
patients after emergency PTCA carried out for
STEMI (Fig. 1). Although after the exclusion of
subjects presenting with cardiogenic shock on ad-
mission absolute mortality rates substantially de-
creased, a significant difference in in-hospital mor-
tality in STEMI patients ‡ and < 70 years old per-
sisted (Fig. 2). We noticed high in-hospital mortality
in STEMI subjects, complicated with cardiogenic
shock without any difference with respect to age
(Fig. 3).
The total duration of hospitalisation was sig-
nificantly greater in the case of patients aged
‡ 70 years than for younger ones (Table 3). As far
as the relation between the duration of hospitalisa-
tion and particular indication for PTCA was con-
cerned, a significant prolongation of in-hospital stay
was noted in elderly patients assigned a diagnosis
of UA/NSTEMI or STEMI.
Multivariable analysis
After adjustment for variables from Tables 1
and 2 advanced age remained an independent pre-
dictor of increased in-hospital mortality in the
Figure 3. Comparison of in-hospital mortality among
patients with ST-elevation myocardial infarction com-
plicated with cardiogenic shock.
Figure 1. Comparison of in-hospital mortality rates;
SA  stable angina; UA  unstable angina; STEMI 
ST-elevation myocardial infarction; NSTEMI  non-ST-
-elevation myocardial infarction
0%
NS
50
45.4
40%
60%
80%
20%
Patients 70 years‡
Patients < 70 years
Figure 2. Comparison of in-hospital mortality rates after
excluding patients with cardiogenic shock; SA  sta-
ble angina; UA  unstable angina; STEMI  ST-eleva-
tion myocardial infarction; NSTEMI  non-ST-eleva-
tion myocardial infarction.
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logistic regression model (Table 4). In addition, ad-
vanced age was associated with longer exposure to
X-rays as a surrogate of procedure complexity
(Table 5). Nevertheless, we did not establish any
relation between age and the volume of contrast
media administered.
Discussion
The continuous ageing of the population is be-
coming a serious problem, affecting the social and
healthcare systems of many countries by generat-
ing high expenses. According to the latest
Table 3. Duration of hospitalisation according to indications for percutaneous transluminal coronary
angioplasty in the groups compared.
Duration of hospitalisation [days] Patients ‡ 70 years Patients < 70 years p
(n = 233)  (n = 767)
All indications 6.5 – 6.3 4.9 – 5.3 < 0.0003
Stable angina 2.8 – 2.5 2.9 – 4.4 NS
Unstable angina/non-ST-segment elevation 9.1 – 8.9 6.2 – 7.1 < 0.02
myocardial infarction
ST-segment elevation myocardial infarction  8.6 – 5.4   7.4 – 4.2 < 0.03
Table 4. Independent predictors of in-hospital mortality in the entire investigated population and in the
age-related subgroups of patients.
Variable Variant OR 95%CI p
The entire population
Cardiogenic shock on admission Present vs. absent 35.74 11.39112.20 < 0.0001
Final flow in the culprit vessel TIMI 0 or 1 vs. TIMI 2 or 3 6.09 1.7720.99 < 0.005
Indication for PTCA STEMI vs. SA 10.43 1.7263.43 < 0.02
STEMI vs. UA/NSTEMI vs. SA 3.23 1.317.96 < 0.02
History of diabetes mellitus Diabetic patients vs. 5.00 1.7014.73 < 0.004
non-diabetic patients
Gender Male vs. female 3.68 1.1312.01 < 0.04
Age Patient ‡ 70 years vs. 2.90 1.087.75 < 0.04
patients < 70 years
1 year increase in age 1.05 1.011.10 < 0.03
History of myocardial infarction Prior myocardial infarction vs. 2.97 1.068.36 < 0.04
lack of prior myocardial infarction
Body mass index 1 kg/m2 increase in body mass index 1.14 1.011.29 < 0.04
History of statin therapy Prior statin therapy vs. 0.18 0.060.55 < 0.003
lack of prior statin therapy
Elderly patients ‡ 70 years old
Cardiogenic shock on admission Present vs. absent 16.46 3.7172.96 < 0.0003
Indication for PTCA STEMI vs. SA 11.04 0.84145.50 0.066*
STEMI vs. UA/NSTEMI vs. SA 3.32 0.9112.06 0.066*
Final flow in the vessel with TIMI 0 or 1 vs. TIMI 2 or 3 8.76 1.8341.93 < 0.007
the tightest stenosis
History of diabetes mellitus Diabetic patients vs. 4.21 1.0416.95 < 0.05
non-diabetic patients
Younger patients < 70 years old
Cardiogenic shock on admission Present vs. absent 46.87 11.63188.94 < 0.0001
Indication for PTCA STEMI vs. SA 31.44 2.58382.99 < 0.007
STEMI vs. UA/NSTEMI vs. SA 5.61 1.6119.57 < 0.007
Smoking Non-smokers vs. 10.62 2.6442.67 < 0.001
current or past smokers
*Borderline significance; PTCA  percutaneous transluminal coronary angioplasty, STEMI  ST-segment elevation myocardial infarction,
NSTEMI  non-ST-segment elevation myocardial infarction, UA  unstable angina, SA  stable angina
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demographic research, the population of elderly
people in Poland is constantly growing [13]. An ap-
proximately twofold increase in the number of pen-
sioners is expected in Poland by the year 2030 [14].
Since the pioneer PTCA procedure performed
by Gruntzig in 1977, the method has undergone
continual improvement (for instance in the intro-
duction of stenting and potent adjunctive pharma-
cotherapy). It is currently the most common ap-
proach to myocardial revascularisation for different
manifestations of CAD. Although the risk of peripro-
cedural complications is higher in elderly patients,
the continuous development of invasive cardiology
is bringing about an increase in the efficacy and
safety of this therapeutical method [15, 16].
Our study provides evidence for the effective-
ness of PTCA in elderly patients in the real world
setting. Investigating a relatively large sample of
subjects undergoing percutaneous revascularisation
we characterised senior patients clinically and an-
giographically and identified factors unfavourably
affecting in-hospital outcome in the elderly as well
as the general population.
Elderly patients in our registry when compared
to younger subjects were characterised by a higher
prevalence of diabetes mellitus, arterial hyperten-
sion, chronic heart failure and prior stroke, along with
a lower proportion of those of male gender, smok-
ers, those with a family history of CAD and subjects
with hypercholesterolaemia. This distribution of risk
factors and comorbidities corresponds to previous
reports [1719] and, as demonstrated in our study,
has a profound impact on the clinical outcome.
As regards the extent of coronary atheroscle-
rosis, the populations compared displayed differenc-
es in the number of vessels affected with athero-
sclerothic lesions. As expected, multivessel CAD
was detected more frequent in elderly than in
younger patients (81.1% vs. 63.8%; p < 0.00001).
This finding is consistent with data from the litera-
ture, which report the presence of multivessel CAD
in symptomatic elderly patients to be clearly more
common than in younger ones. More complex mor-
phology (type B or C according to AHA/ACC clas-
sification) and tighter stenoses are observed in
atherosclerotic lesions in the elderly [79, 15].
These findings were also confirmed in angiograph-
ic research by Thompson et al. [20], who demon-
strated the occurrence of triple-vessel coronary dis-
ease in 44% of patients aged 6574 compared with
63% of patients aged over 75. In the year 2000 an
analysis of data from the National Cardiovascular
Network was published, in which a group of 7 472
patients aged 80 years and over (mean age 83 years)
was compared with a population of 102 236 young-
er patients (mean age 62 years). In keeping with our
results, the occurrence of multivessel coronary dis-
ease was significantly higher in elderly patients
(57% vs. 45%; p < 0.01). Additionally, a higher in-
cidence of involvement of the left main and
Table 5. Impact of variables from Tables 1 and 2 on X-ray exposure time in the entire population.
Model characteristics: R = 0.54; R2 = 0.30; p < 0.000001.
Coefficient Standard error Slope B Standard error P
BETA of coefficient of slope B
BETA
Intercept 6.3153 1.9478 < 0.002
Indication for PTCA 0.1025 0.0321 0.7381 0.2315 < 0.002
STEMI vs. UA/NSTEMI vs. SA
Age 0.0848 0.0283 0.0507 0.0169 < 0.003
Body mass index 0.0574 0.0268 0.0983 0.0459 < 0.04
Hypercholesterolaemia absent vs. present 0.0670 0.0280 1.1051 0.4615 < 0.02
Recanalisation 0.0759 0.0294 1.5892 0.6160 < 0.02
Number of dilated arteries 0.0908 0.0279 3.3454 1.0295 < 0.002
Baseline flow in culprit vessel 0.0869 0.0348 1.1770 0.4706 < 0.02
TIMI 2 or 3 vs. TIMI 0 or 1
Number of used balloons 0.3723 0.0289 3.0130 0.2338 < 0.000001
Number of implanted stents 0.2320 0.0303 2.3926 0.3121 < 0.000001
Angiographic outcome of PTCA 0.2466 0.0326 6.2824 0.8306 < 0.000001
effective vs. ineffective
Revascularisation complete vs. incomplete 0.0892 0.0285 1.3041 0.4161 < 0.002
PTCA  percutaneous transluminal coronary angioplasty, STEMI  ST-segment elevation myocardial infarction, NSTEMI  non-ST-segment elevation
myocardial infarction, UA  unstable angina, SA  stable angina
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proximal left anterior descending artery was observed
in the elderly group [15]. In our study we excluded
patients with involvement of the left main coronary
artery and did not differentiate segments of the
major coronary branches. No direct comparison may
therefore be made.
The introduction of stenting within the context
of invasive cardiology has created new therapeuti-
cal possibilities. The percentage of stent implanta-
tions rapidly increased from 6% in 1994 to 66% in
1997 and has been growing further [15]. It is
currently estimated that 8090% of PTCA proce-
dures incorporate stent implantation [21]. With re-
gard to the incidence of balloon angioplasty in com-
parison with coronary stenting, we found that the
first was a relatively more common practice in the
group of patients ‡ 70 years of age (23.4% vs.
16.5%, p < 0.04), while the latter was more frequent-
ly performed in younger patients (83.5% vs. 76.6%;
p < 0.04). The background for this finding could be
the fact that stent implantation in older individuals
is likely to be more complicated as a result of the tor-
tuosity of the coronary vessels and the greater extent
of atherosclerotic lesions, often accompanied by mas-
sive calcifications (type C according to ACC/AHA
classification) [22]. In 2003 Kobayashi et al. [23]
performed an analysis of the in-hospital and long-
-term outcome of patients with multivessel coronary
artery disease treated with stent implantation and
divided according to age into two groups: those
80 years and over (n = 75) and those below 80 years
of age (n = 894). The authors concluded that, de-
spite the high degree of technical feasibility, there
was a higher incidence of early cardiac and non-car-
diac complications as well as a higher mortality in
one-year follow-up in the older group [23].
Our study also demonstrated that PTCA pro-
cedures in patients over 70 years of age tend to
be more time and labour-consuming, which is like-
ly to be due to the presence of more advanced
atherosclerotic lesions within the coronary arter-
ies. In this group of patients the total procedure
duration was longer. However, the difference did
not reach statistical significance. Similarly, PTCA
procedures in this age group also required marked-
ly longer exposition to X-rays. This was confirmed
in univariate as well as multivariate analysis. The
volume of contrast media utilised in elderly pa-
tients was also higher. The above-mentioned fac-
tors may indicate a higher degree of procedural
difficulty in older patients.
A trial comparing PTCA procedures performed
between 1994 and 1997 on patients over 80 years
of age showed a gradual improvement in the effec-
tiveness of this method (from 81% to 86%; p = 0.009)
[15]. In our study the efficacy of coronary interven-
tions estimated on the basis of clinical and angio-
graphic criteria was high and equal to 91.4% in the
elderly and 93.6% in the younger group.
The possibility of performing complete revas-
cularisation depends heavily on the age of the pa-
tient. The number, localisation and morphology of
coronary lesions, as well as the anatomy of the cor-
onary vessels themselves, have been identified as
the factors which have the strongest direct influ-
ence on the outcome of PTCA procedures. In eld-
erly patients the following angiographic changes are
common findings: total occlusion of a coronary ves-
sel, calcified eccentric stenoses localised at vessel
bends or bifurcations and tortuosity of the coronary
arteries [22, 24]. The features given above reduce
the probability of successful dilatation or recanali-
sation of the stenotic regions and so the chance of
total revascularisation decreases [20, 25]. Lack of
complete revascularisation increases the risk of
a recurrence of symptoms in elderly people and is
associated with poorer long-term prognosis. De
Gregorio et al. [26] compared a group of patients
aged ‡ 75 years (n = 137) with a group of patients
aged < 75 years (n = 2551) who underwent PTCA
with stenting between March 1993 and July 1997.
Complete anatomical revascularisation was
achieved in 56% of the younger patients but in only
31% of patients from the first group (p = 0.008) [26].
In our research the percentage of complete revas-
cularisations in patients < 70 years old was also sig-
nificantly higher (26.7% vs. 12.0% for those ‡ 70
years old; p < 0.0001). The main explanation for
the difference between our results and the results
from the study cited above is the high percentage
of patients treated for STEMI in our population
(39.5% in the elderly and 32.9% in the younger
group) and the significantly lower prevalence of
CAD risk factors (diabetes mellitus and hyperten-
sion) in the study by de Gregorio when compared
to our material. Our approach to patients present-
ing with STEMI without cardiogenic shock was
immediate PTCA limited to the culprit lesion, while
further stages of revascularisation were usually
postponed and performed electively. The study cit-
ed above [26] included no STEMI patients at all,
which must have affected the statistics and hence
the difference in the final outcomes of the invasive
procedures, including the rate of complete revas-
cularisations.
Another interesting issue, which deserves sep-
arate comment, is the in-hospital mortality of elder-
ly patients treated for CAD with invasive procedures.
151
Adam Sukiennik et al., Percutaneous coronary angioplasty in elderly patients
www.cardiologyjournal.org
Numerous retrospective analyses of clinical trials
indicate that age is a powerful risk factor for com-
plications of coronary invasive procedures [27, 28].
A retrospective analysis performed in the Mayo
Clinic between 19791997 on 1597 patients treat-
ed with PTCA for myocardial infarction demonstrat-
ed in-hospital mortality rates of 4%, 9%, 13% and
21% for patients aged 5059, 6069, 7079 and
‡ 80, respectively [29]. Sakai et al. [30] confronted
the results of invasive treatment for acute myocar-
dial infarction in patients over and below 75 years
of age. The first group demonstrated a significant-
ly higher in-hospital mortality rate than the young-
er patients (8.4% vs. 3.7%; p < 0.01) [30], despite
similarity in the rates for successful reperfusion
(93% vs. 95%, p = NS). In the context of the re-
sults of this study, successful reperfusion had the
strongest impact on the final outcome in both age
groups. The in-hospital mortality rate in the elder-
ly group was equal to 6.6% when the reperfusion
attempt was successful, but rose to 33% in the case
of reperfusion failure (p < 0.0001). The percentages
for the younger group were less harsh and equalled
3.0% and 18% respectively (p < 0.0001) [30]. The
directly proportional relation between the age of
the patients and the risk of the PTCA procedure
was demonstrated by a study by Taddei et al. [31],
where elective and emergency PTCA procedures
performed on 21 516 patients were analysed. The
in-hospital mortality rate in the study group was
0.42% for patients of 5059 years old, 1.22% for
patients of 7079 years old and 2.93% for patients
over 80 years of age. The mortality rate after 5 years
was 7%, 24% and 35% respectively. In a report on
patients treated with PTCA delivered in the year
2000 by the National Cardiovascular Network
a marked increase in mortality was noted among pa-
tients over 85 years old when compared with those
below 55 years of age (5% vs. 0.5%) [15]. In our
study the overall in-hospital mortality rate in eld-
erly patients was significantly higher than for
younger patients (6.9% vs. 2.1%; p < 0.0003). We
ascertained that of the different manifestations of
CAD myocardial infarction is, as expected, charac-
terised by the highest mortality rate (15.9% in the
elderly vs. 5.5% in the younger group; p < 0.003).
This observation is consistent with the studies con-
ducted by Tresch et al. [32], who found that in-hos-
pital mortality due to myocardial infarction is three
times as high in the elderly population as in young-
er patients. To a certain degree this high mortality
rate could be explained by a beneficial modification
in the course of myocardial infarction as a result of
prior ischemia-related preconditioning of the heart
muscle in younger individuals, which is, however,
absent in patients over 70 years old [33].
We report a significantly higher proportion of
patients with STEMI complicated with cardiogenic
shock in the elderly population. In the SHOCK reg-
istry such subjects were less likely to be treated
with invasive therapies than younger patients with
shock. Covariate-adjusted modelling revealed that
elderly patients selected for early revascularisation
had a lower mortality rate than those undergoing
a revascularisation procedure later or not at all [5].
In this challenging subgroup our data showed an in-
hospital mortality of 50% when compared to 48%
in the SHOCK registry.
To date the best evidence for establishing in-
vasive or surgical treatment as the most efficient
method of treatment of coronary disease was de-
livered in the APPROACH study [34]. Among pa-
tients aged 7079, subjected in a non-randomised
manner to different methods of treatment for CAD
the survival rate at a 4-year follow-up was 87.3%
for CABG, 83.9% for PTCA and 79.1% for conser-
vative treatment. The corresponding results for the
population over 80 years of age were generally poor-
er and equalled 77.4%, 71.6% and 60.3% respective-
ly. Subsequently it was in this particular age group
that the superiority of invasive treatment could
most clearly be seen. Klein [35] is of the opinion
that coronary angioplasty, as less invasive than cor-
onary artery bypass grafting and requiring a short-
er recovery time, provides particular benefits in the
elderly with coexisting non-cardiac disorders that pose
significant additional operative risk. A simplified ap-
proach frequently adopted for senior patients, with
incomplete PTCA or PTCA of the culprit lesion
only, may be an option even in multivessel disease.
According to Rossi et al. [36], this minimises
periprocedural complications while still allowing
a meaningful clinical recovery in patients with inher-
ent functional limitations related to age itself. Unfor-
tunately, our study does not address these issues.
We demonstrated that hospitalisation was of
seriously longer duration for elderly than for young-
er patients. This was related to numerous comor-
bidities which coexisted in the elderly patients,
leading to pharmacotherapeutical differences be-
tween the two age groups and to a slower pace of
intensification of pharmacological treatment in the
elderly group, which eventually resulted in prolon-
gation of the recovery period in this group [37].
The study limitations include the use of regis-
tration data and its retrospective character and re-
striction to the experience of a single centre.
Although we investigated a heterogeneous population
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in terms of CAD manifestation, we adjusted for the
clinical presentation in a multivariable analysis. It
would also be valuable to compare the outcomes of
percutaneous revascularisations with coronary ar-
tery bypass grafting as well as medical therapy
in the elderly population and to identify subjects
in whom particular treatment confers a survival
advantage. Nevertheless, randomised large-scale
prospective trials are warranted to obtain conclu-
sive results. Surprisingly, in a multivariate analy-
sis male gender was associated with a 3.8-fold in-
creased OR of in-hospital mortality. In the published
data women referred for interventional treatment
consistently presented with unfavourable baseline
characteristics [3847]. Although recent studies
have indicated improved short-term prognoses for
women [38] or even a lack of gender impact on in-
hospital outcome [3942], our finding is not a com-
mon belief [4345]. Nevertheless, BARI investiga-
tors reported that female gender was an independ-
ent predictor of increased 5-year survival in surgical
as well as interventional arm [46]. Similarly, Berg-
er et al. [47], after a recent analysis of 4284 patients
undergoing coronary angioplasty, concluded that fe-
male gender conferred a long-term survival advan-
tage despite more high-risk characteristics. Light
has been cast on the tendency observed in recent
trials for outcome to be improved for women by the
frequent use of new evidence-based medical ther-
apies and interventional devices. However, we can-
not fully exclude the possibility that our analysis,
like other retrospective studies without randomi-
sation, may have been confounded by unrecognised
variables or selection bias.
Currently a clopidogrel loading dose of 300 mg
is only recommended when administered at least
6 hours before the intervention, ideally the day be-
fore. Otherwise, 600 mg of clopidogrel is advised [48].
Although a large majority of our patients were
treated with stenting, use of this device has con-
stantly been on the increase over recent years.
Coronary stenting, particularly in elderly patients,
may therefore be more widespread currently than
shown in our data.
Conclusions
To sum up, despite frequent comorbidities and
more extensive coronary athersoclerosis, a high rate
of procedural success was demonstrated in the eld-
erly population undergoing PTCA. However, after
adjustment for the baseline characteristics advanced
age was still associated with a less favourable in-hos-
pital outcome and greater procedural complexity.
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